Elli Peselev

Array ( [id] => 4833987 [patent_doc_number] => 20080132534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Pharmaceutical composition comprising a macrolide immunomodulator' [patent_app_type] => utility [patent_app_number] => 11/973849 [patent_app_country] => US [patent_app_date] => 2007-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3381 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132534.pdf [firstpage_image] =>[orig_patent_app_number] => 11973849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786160 [patent_doc_number] => 20080139489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'USE OF KETOLIDES FOR PREVENTING ARTERIAL THROMBOTIC COMPLICATIONS RELATED TO ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 11/863329 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1558 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139489.pdf [firstpage_image] =>[orig_patent_app_number] => 11863329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5429083 [patent_doc_number] => 20090088393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS' [patent_app_type] => utility [patent_app_number] => 11/864113 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6679 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088393.pdf [firstpage_image] =>[orig_patent_app_number] => 11864113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183910 [patent_doc_number] => 08623842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Hemostatic agent and method' [patent_app_type] => utility [patent_app_number] => 11/861719 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 4865 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11861719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786161 [patent_doc_number] => 20080139490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Crystalline forms of valrubicin and processes for their preparation' [patent_app_type] => utility [patent_app_number] => 11/904066 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6517 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139490.pdf [firstpage_image] =>[orig_patent_app_number] => 11904066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786159 [patent_doc_number] => 20080139488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea' [patent_app_type] => utility [patent_app_number] => 11/898911 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2489 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139488.pdf [firstpage_image] =>[orig_patent_app_number] => 11898911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189306 [patent_doc_number] => 08183229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Bone filling complex and method for fabricating the same' [patent_app_type] => utility [patent_app_number] => 12/438628 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 6559 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183229.pdf [firstpage_image] =>[orig_patent_app_number] => 12438628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922760 [patent_doc_number] => 20080071077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Cosmetic formulations comprising carboxymethyl cellulose' [patent_app_type] => utility [patent_app_number] => 11/895731 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3236 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20080071077.pdf [firstpage_image] =>[orig_patent_app_number] => 11895731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705121 [patent_doc_number] => 20080064645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Non-Natural Sphingolipid Analogs and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/839024 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9787 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064645.pdf [firstpage_image] =>[orig_patent_app_number] => 11839024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685435 [patent_doc_number] => 20100120706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Macrolides Useful Against Inflammatory and Allergic Diseases' [patent_app_type] => utility [patent_app_number] => 12/375963 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19122 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120706.pdf [firstpage_image] =>[orig_patent_app_number] => 12375963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772642 [patent_doc_number] => 20080058301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Formulations' [patent_app_type] => utility [patent_app_number] => 11/835367 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 64603 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058301.pdf [firstpage_image] =>[orig_patent_app_number] => 11835367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132888 [patent_doc_number] => 07696189 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-04-13 [patent_title] => 'Prostate and breast cancer treatment' [patent_app_type] => utility [patent_app_number] => 11/835394 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 64612 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696189.pdf [firstpage_image] =>[orig_patent_app_number] => 11835394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4910239 [patent_doc_number] => 20080021006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 11/835334 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 64724 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021006.pdf [firstpage_image] =>[orig_patent_app_number] => 11835334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282911 [patent_doc_number] => 08217013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Polyene diester antibiotics' [patent_app_type] => utility [patent_app_number] => 12/671024 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6267 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92235 [patent_doc_number] => 07737129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Substituted liposaccharides useful in the treatment and prevention of endotoxemia' [patent_app_type] => utility [patent_app_number] => 11/830412 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13853 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737129.pdf [firstpage_image] =>[orig_patent_app_number] => 11830412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916230 [patent_doc_number] => 20080096831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Stabilized azithromycin composition' [patent_app_type] => utility [patent_app_number] => 11/881664 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3540 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096831.pdf [firstpage_image] =>[orig_patent_app_number] => 11881664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652150 [patent_doc_number] => 20080039406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => '3,6-BRIDGED TYLOSIN DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/828473 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15845 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039406.pdf [firstpage_image] =>[orig_patent_app_number] => 11828473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852585 [patent_doc_number] => 20080318328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products' [patent_app_type] => utility [patent_app_number] => 11/878793 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318328.pdf [firstpage_image] =>[orig_patent_app_number] => 11878793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305896 [patent_doc_number] => 08227429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Macrolide synthesis process and solid-state forms' [patent_app_type] => utility [patent_app_number] => 11/828404 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 33768 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11828404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398308 [patent_doc_number] => 20090318371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'TOPICAL ANTIACNE PREPARATIONS CONTAINING RETINOID (TAZAROTENE OR ADAPALENE), ANTIBIOTIC (CLINDAMYCIN PHOSPHATE) AND/OR KERATOLYTIC (MICROSPONGED BENZOYL PEROXIDE)' [patent_app_type] => utility [patent_app_number] => 12/375592 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1922 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318371.pdf [firstpage_image] =>[orig_patent_app_number] => 12375592 [rel_patent_id] =>[rel_patent_doc_number] =>)